Target intelligence / Profile preview

Eukaryotic Translation Initiation Factor 2-Alpha Kinase HRI (HRI)

Target
HRI
Molecular classification
Enzyme, Serine/threonine-protein kinase, Stress response kinase
01

Overview

HRI is a key regulator of protein synthesis in mammalian cells, acting as a kinase that phosphorylates the alpha subunit of eukaryotic translation initiation factor 2 (eIF2α) in response to various cellular stresses. Its primary function is to sense heme availability and other stress signals, such as oxidative stress, osmotic shock, mitochondrial dysfunction, and heat shock. Upon activation, HRI phosphorylates eIF2α, which inhibits the recycling of eIF2 and leads to a global reduction in protein synthesis while allowing selective translation of specific mRNAs involved in the integrated stress response (ISR). This mechanism helps cells adapt by reprogramming gene expression during periods of metabolic or environmental stress. It is predominantly expressed in erythroid precursors and plays an essential role during erythropoiesis by coordinating ribosomal protein translation. Dysregulation can lead to ineffective erythropoiesis due to unrestrained globin synthesis when heme is limiting. It may also play roles in neurodegeneration or immune dysfunction.

Other names
Heme-Regulated InhibitorEIF2AK1E2AK1_HUMAN
02

Mechanism of action

Inhibition of eIF2α recycling via phosphorylation, leading to global reduction in cap-dependent protein synthesis and selective translation of stress-related mRNAs.

03

Biological functions

Regulation of protein synthesisIntegrated stress response (ISR) activationeIF2α phosphorylationRegulation of mRNA translationHeme sensingProteostasis maintenance
04

Disease associations

Ineffective erythropoiesisNeurodegeneration (potential)Immune dysfunction (potential)
05

Safety considerations

Dysregulation can lead to ineffective erythropoiesis.Potential involvement in neurodegenerative diseases.

Beyond the preview

Go deeper on Eukaryotic Translation Initiation Factor 2-Alpha Kinase HRI (HRI).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic Translation Initiation Factor 2-Alpha Kinase HRI (HRI).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call